@article{amiot:hal-01639670,
TITLE = {One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study},
AUTHOR = {Amiot, A. and Serrero, M. and Peyrin-Biroulet, L. and Filippi, J. and Pariente, B. and Roblin, X. and Buisson, A. and Stefanescu, C. and Trang-Poisson, C. and Altwegg, R. and Marteau, P. and Vaysse, T. and Bourrier, A. and Nancey, S. and Laharie, D. and Allez, M. and Savoye, G. and Moreau, J. and Vuitton, L. and Viennot, S. and Aubourg, A. and Pelletier, A.-L. and Bouguen, G. and Abitbol, V. and Gagniere, C. and Bouhnik, Y.},
URL = {https://uca.hal.science/hal-01639670},
JOURNAL = {Alimentary Pharmacology \& Therapeutics (Suppl)},
VOLUME = {46},
NUMBER = {3},
PAGES = {310-321},
YEAR = {2017},
MONTH = Aug, DOI = {10.1111/apt.14167},
HAL_ID = {hal-01639670},
HAL_VERSION = {v1},
}